Litcius/Paper detail

Elevated Lipoprotein(a) as a potential residual risk factor associated with lipid-rich coronary atheroma in patients with type 2 diabetes and coronary artery disease on statin treatment: Insights from the REASSURE-NIRS registry

Hayato Nakamura, Yu Kataoka, Stephen J. Nicholls, Rishi Puri, Satoshi Kitahara, Kota Murai, Kenichiro Sawada, Hideo Matama, Takamasa Iwai, Satoshi Honda, Masashi Fujino, Kensuke Takagi, Shuichi Yoneda, Fumiyuki Otsuka, Kensaku Nishihira, Yasuhide Asaumi, Kenichi Tsujita, Teruo Noguchi

2022Atherosclerosis23 citationsDOI

Topics & Concepts

MedicineDiabetes mellitusInternal medicineCoronary artery diseaseLipoprotein(a)StatinType 2 diabetesCardiologyRisk factorLipoproteinResidual riskCholesterolGastroenterologyEndocrinologyLipoproteins and Cardiovascular HealthCoronary Interventions and DiagnosticsAtherosclerosis and Cardiovascular Diseases
Elevated Lipoprotein(a) as a potential residual risk factor associated with lipid-rich coronary atheroma in patients with type 2 diabetes and coronary artery disease on statin treatment: Insights from the REASSURE-NIRS registry | Litcius